| Transfusion transmission of cytomegalovirus confirmed by restriction endonuclease analysis MD Tolpin, JA Stewart, D Warren, BA Mojica, MA Collins, SA Doveikis, ... The Journal of pediatrics 107 (6), 953-956, 1985 | 88 | 1985 |
| Intraperitoneal transplantation of bioengineered humanized liver grafts supports failing liver in acute condition SK Vishwakarma, A Bardia, C Lakkireddy, N Raju, SAB Paspala, ... Materials Science and Engineering: C 98, 861-873, 2019 | 23 | 2019 |
| Use of biocompatible sorafenib-gold nanoconjugates for reversal of drug resistance in human hepatoblatoma cells SK Vishwakarma, P Sharmila, A Bardia, L Chandrakala, N Raju, ... Scientific reports 7 (1), 8539, 2017 | 22 | 2017 |
| Bioengineered humanized livers as better three-dimensional drug testing model system SK Vishwakarma, A Bardia, C Lakkireddy, R Nagarapu, MA Habeeb, ... World Journal of Hepatology 10 (1), 22, 2018 | 13 | 2018 |
| Cu-Catalyzed ligand-free synthesis of rosuvastatin based novel indole derivatives as potential anticancer agents KS Kumar, B Rajesham, MS Ramulu, B Bhaskar, SN Dash, MA Ashfaq, ... RSC advances 6 (102), 100487-100493, 2016 | 13 | 2016 |
| Molecular dynamics of pancreatic transcription factors in bioengineered humanized insulin producing neoorgan SK Vishwakarma, C Lakkireddy, A Bardia, N Raju, SAB Paspala, ... Gene 675, 165-175, 2018 | 12 | 2018 |
| Fabrication of decellularized amnion and chorion scaffolds to develop bioengineered cell-laden constructs C Lakkireddy, SK Vishwakarma, N Raju, SI Ahmed, A Bardia, MA Khan, ... Cellular and Molecular Bioengineering, 1-14, 2022 | 7 | 2022 |
| Biofabricated humanized insulin producing neo-organs generates secondary neo-organoids through ectopic transplantation SK Vishwakarma, C Lakkireddy, A Bardia, R Nagarapu, SAB Paspala, ... Cellular and Molecular Bioengineering 12, 569-582, 2019 | 5 | 2019 |
| Role of drug transporters and heat shock proteins during ethanol exposure to human neural precursor cells and its lineages SK Vishwakarma, N Fatima, C Lakkireddy, N Raju, A Bardia, A Sandhya, ... Tissue and Cell 51, 14-23, 2018 | 5 | 2018 |
| Biofabrication of allogenic bone grafts using cellularized amniotic scaffolds for application in efficient bone healing C Lakkireddy, SK Vishwakarma, A Bardia, N Raju, SI Ahmed, SM Fathima, ... Tissue and Cell 73, 101631, 2021 | 4 | 2021 |
| Association of CD14 and macrophage migration inhibitory factor gene polymorphisms with inflammatory microRNAs expression levels in ankylosing spondylitis and polyarthralgia SK Vishwakarma, C Lakkireddy, G Sravani, BVS Sastry, N Raju, ... International Journal of Immunogenetics 45 (4), 190-200, 2018 | 4 | 2018 |
| Protective role of hypothermia against heat stress in differentiated and undifferentiated human neural precursor cells: A differential approach for the treatment of traumatic … SK Vishwakarma, A Bardia, N Fathima, L Chandrakala, S Rahamathulla, ... Basic and Clinical Neuroscience 8 (6), 453, 2017 | 4 | 2017 |
| A meta-analysis of genotyping methods and nucleotide variation in Hepatitis C Virus R Nagarapu, S Rahamathulla, SK Vishwakarma, SK Vinjimuri, R Rao, ... Int J Adv Res 1 (8), 439-49, 2013 | 4 | 2013 |
| TiO2 Nanoflowers on Conducting Substrates Ameliorate Effective Transdifferentiation of Human Hepatic Progenitor Cells for Long‐Term Hyperglycemia Reversal … SK Vishwakarma, J Jaiswal, KH Park, C Lakkireddy, N Raju, A Bardia, ... Advanced Therapeutics 3 (8), 1900205, 2020 | 3 | 2020 |
| Genetic polymorphisms of X-ray repair cross-complementing group 1 and apurinic/apyrimidinic endonuclease-1 in chronic obstructive pulmonary disease A Bardia, SK Vishwakarma, CL Reddy, N Raju, S Iqbal, G Sravani, ... Inflammation 39, 1198-1204, 2016 | 3 | 2016 |
| Determination of Sustained Virological Response in Hepatitis C Virus Genotypes by the Number of Mutations in the E2 and NS5A-ISDR Regions: A Meta-Analysis S Rahamathulla, B Ratnagiri, M Manickam, S Sultana, DM Mamatha, ... Russian journal of genetics 54, 1013-1024, 2018 | 2 | 2018 |
| Varied Virological Response of Patients with Chronic Hepatitis C against the Treatment of Pegylated Interferon-α and Ribavirin N Tabassum, Z Raheem, A Yasmin, MN Ilyas, AH Mohd, R Nagarapu, ... IOSR J. Pharm 4 (1), 67-73, 2014 | 2 | 2014 |
| Genetic Determinants Involved in the Osteoporosis Pathophysiology M Nooreen, S Fatima, R Nagarapu, MA Khan, AA Khan Current Pharmacogenomics and Personalized Medicine (Formerly Current …, 2020 | 1 | 2020 |
| Qualitative prevalence assessment of SARS-CoV2 infection by comparing first, second and third wave data: A sentinel surveillance testing centre study Nagarapu R, Annapoorna SL, Gurappagari P, Shailaja VV, Bommala ML J Med Sci Res. 10 (3), 128-132, 2022 | | 2022 |
| Establishing a unique micro RNAs panel with viral load for real-time assessment of disease status, therapeutic response and relapse in HCV patients R Nagarapu, SI Ahmed, SK Vishwakarma, A Bardia, C Lakkireddy, ... International Journal of Infectious Diseases 101, 187-188, 2020 | | 2020 |
